SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'TDC'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N4H_A_REAA500_1 (NUCLEAR RECEPTORROR-BETA) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 5 / 11 | ILE A 99ARG A 94VAL A 145LEU A 60ALA A 89 | NoneNoneNoneTDC A 301 ( 4.9A)None | 1.18A | 1n4hA-5mruA:undetectable | 1n4hA-5mruA:15.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FJ1_A_CTCA222_0 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 7 / 12 | HIS A 64PHE A 86HIS A 100ARG A 104PRO A 105THR A 112GLN A 116 | TDC A 301 (-3.8A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.0A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A) | 0.66A | 2fj1A-5mruA:23.8 | 2fj1A-5mruA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FJ1_A_CTCA222_0 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 8 / 12 | HIS A 64SER A 67PHE A 86HIS A 100PRO A 105THR A 112GLN A 116SER A 138 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A)TDC A 301 ( 3.7A) | 0.83A | 2fj1A-5mruA:23.8 | 2fj1A-5mruA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2O7O_A_DXTA222_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 5 / 12 | HIS A 64SER A 67ASN A 82HIS A 100ILE A 137 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A) MG A 302 ( 3.2A)TDC A 301 ( 4.5A) | 1.39A | 2o7oA-5mruA:23.8 | 2o7oA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2O7O_A_DXTA222_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 9 / 12 | HIS A 64SER A 67ASN A 82PHE A 86HIS A 100ARG A 104PRO A 105THR A 112GLN A 116 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.0A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A) | 0.66A | 2o7oA-5mruA:23.8 | 2o7oA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2O7O_A_DXTA222_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 9 / 12 | HIS A 64SER A 67ASN A 82PHE A 86HIS A 100PRO A 105THR A 112GLN A 116SER A 138 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A)TDC A 301 ( 3.7A) | 0.72A | 2o7oA-5mruA:23.8 | 2o7oA-5mruA:47.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2TCT_A_CTCA222_0 (TETRACYCLINEREPRESSOR) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 7 / 12 | HIS A 64PHE A 86HIS A 100ARG A 104PRO A 105THR A 112GLN A 116 | TDC A 301 (-3.8A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.0A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A) | 0.60A | 2tctA-5mruA:23.8 | 2tctA-5mruA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2TCT_A_CTCA222_0 (TETRACYCLINEREPRESSOR) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 7 / 12 | HIS A 64SER A 67PHE A 86HIS A 100PRO A 105THR A 112GLN A 116 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A) | 0.65A | 2tctA-5mruA:23.8 | 2tctA-5mruA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2TCT_A_CTCA222_0 (TETRACYCLINEREPRESSOR) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 7 / 12 | HIS A 64SER A 67PHE A 86PRO A 105THR A 112GLN A 116SER A 138 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.3A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A)TDC A 301 ( 3.7A) | 0.84A | 2tctA-5mruA:23.8 | 2tctA-5mruA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TRT_A_TACA222_1 (TETRACYCLINEREPRESSOR CLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 7 / 11 | HIS A 64ASN A 82PHE A 86HIS A 100ARG A 104PRO A 105GLN A 116 | TDC A 301 (-3.8A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.0A)TDC A 301 (-4.5A)TDC A 301 (-2.8A) | 0.54A | 2trtA-5mruA:23.9 | 2trtA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TRT_A_TACA222_1 (TETRACYCLINEREPRESSOR CLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 7 / 11 | HIS A 64ASN A 82PHE A 86HIS A 100PRO A 105GLN A 116SER A 138 | TDC A 301 (-3.8A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.5A)TDC A 301 (-2.8A)TDC A 301 ( 3.7A) | 0.62A | 2trtA-5mruA:23.9 | 2trtA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TRT_A_TACA222_1 (TETRACYCLINEREPRESSOR CLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 5 / 11 | HIS A 64SER A 67ASN A 82HIS A 100ILE A 137 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A) MG A 302 ( 3.2A)TDC A 301 ( 4.5A) | 1.42A | 2trtA-5mruA:23.9 | 2trtA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2TRT_A_TACA222_1 (TETRACYCLINEREPRESSOR CLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 7 / 11 | HIS A 64SER A 67ASN A 82PHE A 86HIS A 100GLN A 116SER A 138 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-2.8A)TDC A 301 ( 3.7A) | 0.73A | 2trtA-5mruA:23.9 | 2trtA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2VKE_A_TACA222_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 5 / 11 | HIS A 64SER A 67ASN A 82HIS A 100ILE A 137 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A) MG A 302 ( 3.2A)TDC A 301 ( 4.5A) | 1.32A | 2vkeA-5mruA:24.0 | 2vkeA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2VKE_A_TACA222_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 8 / 11 | HIS A 64SER A 67ASN A 82PHE A 86HIS A 100ARG A 104PRO A 105GLN A 116 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.0A)TDC A 301 (-4.5A)TDC A 301 (-2.8A) | 0.65A | 2vkeA-5mruA:24.0 | 2vkeA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2VKE_A_TACA222_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 8 / 11 | HIS A 64SER A 67ASN A 82PHE A 86HIS A 100PRO A 105GLN A 116SER A 138 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.5A)TDC A 301 (-2.8A)TDC A 301 ( 3.7A) | 0.70A | 2vkeA-5mruA:24.0 | 2vkeA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XPV_A_MIYA1209_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 5 / 12 | HIS A 64SER A 67ASN A 82HIS A 100ILE A 137 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A) MG A 302 ( 3.2A)TDC A 301 ( 4.5A) | 1.46A | 2xpvA-5mruA:24.0 | 2xpvA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XPV_A_MIYA1209_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 9 / 12 | HIS A 64SER A 67ASN A 82PHE A 86HIS A 100ARG A 104PRO A 105THR A 112GLN A 116 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.0A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A) | 0.69A | 2xpvA-5mruA:24.0 | 2xpvA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XPV_A_MIYA1209_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 9 / 12 | HIS A 64SER A 67ASN A 82PHE A 86HIS A 100PRO A 105THR A 112GLN A 116SER A 138 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A)TDC A 301 ( 3.7A) | 0.77A | 2xpvA-5mruA:24.0 | 2xpvA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XPW_A_OTCA222_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 6 / 12 | LEU A 60HIS A 64SER A 67ASN A 82HIS A 100ILE A 137 | TDC A 301 ( 4.9A)TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A) MG A 302 ( 3.2A)TDC A 301 ( 4.5A) | 1.43A | 2xpwA-5mruA:23.4 | 2xpwA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XPW_A_OTCA222_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 9 / 12 | LEU A 60HIS A 64SER A 67ASN A 82PHE A 86HIS A 100ARG A 104PRO A 105GLN A 116 | TDC A 301 ( 4.9A)TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.0A)TDC A 301 (-4.5A)TDC A 301 (-2.8A) | 0.68A | 2xpwA-5mruA:23.4 | 2xpwA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XPW_A_OTCA222_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 9 / 12 | LEU A 60HIS A 64SER A 67ASN A 82PHE A 86HIS A 100PRO A 105GLN A 116SER A 138 | TDC A 301 ( 4.9A)TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.5A)TDC A 301 (-2.8A)TDC A 301 ( 3.7A) | 0.70A | 2xpwA-5mruA:23.4 | 2xpwA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XRL_A_DXTA1211_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 5 / 12 | HIS A 64SER A 67ASN A 82HIS A 100ILE A 137 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A) MG A 302 ( 3.2A)TDC A 301 ( 4.5A) | 1.31A | 2xrlA-5mruA:23.2 | 2xrlA-5mruA:43.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XRL_A_DXTA1211_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 9 / 12 | HIS A 64SER A 67ASN A 82PHE A 86HIS A 100PRO A 105THR A 112GLN A 116SER A 138 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A)TDC A 301 ( 3.7A) | 0.81A | 2xrlA-5mruA:23.2 | 2xrlA-5mruA:43.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XRL_A_DXTA1211_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 6 / 12 | HIS A 64SER A 67ASN A 82THR A 112GLN A 116LEU A 117 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)NoneTDC A 301 (-2.8A)None | 0.61A | 2xrlA-5mruA:23.2 | 2xrlA-5mruA:43.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ABZ_A_T1CA1209_1 (TETRACYCLINEREPRESSOR CLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 9 / 12 | HIS A 64SER A 67ASN A 82PHE A 86HIS A 100PRO A 105THR A 112GLN A 116SER A 138 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A)TDC A 301 ( 3.7A) | 0.78A | 4abzA-5mruA:23.2 | 4abzA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ABZ_A_T1CA1209_1 (TETRACYCLINEREPRESSOR CLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 5 / 12 | SER A 67ARG A 104PRO A 105THR A 112GLN A 116 | TDC A 301 (-3.3A)TDC A 301 (-4.0A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A) | 1.03A | 4abzA-5mruA:23.2 | 4abzA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4AC0_A_MIYA1204_1 (TETRACYCLINEREPRESSOR PROTEINCLASS B FROMTRANSPOSON TN1 0) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 6 / 12 | HIS A 64ASN A 82ARG A 104PRO A 105THR A 112GLN A 116 | TDC A 301 (-3.8A)TDC A 301 (-3.2A)TDC A 301 (-4.0A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A) | 0.94A | 4ac0A-5mruA:24.9 | 4ac0A-5mruA:44.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4AC0_A_MIYA1204_1 (TETRACYCLINEREPRESSOR PROTEINCLASS B FROMTRANSPOSON TN1 0) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 7 / 12 | HIS A 64ASN A 82PHE A 86HIS A 100PRO A 105THR A 112GLN A 116 | TDC A 301 (-3.8A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A) | 0.68A | 4ac0A-5mruA:24.9 | 4ac0A-5mruA:44.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B3A_A_TACA222_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 7 / 12 | LEU A 60HIS A 64ASN A 82PHE A 86ARG A 104PRO A 105GLN A 116 | TDC A 301 ( 4.9A)TDC A 301 (-3.8A)TDC A 301 (-3.2A)TDC A 301 (-3.3A)TDC A 301 (-4.0A)TDC A 301 (-4.5A)TDC A 301 (-2.8A) | 0.58A | 4b3aA-5mruA:24.0 | 4b3aA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B3A_A_TACA222_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 7 / 12 | LEU A 60HIS A 64ASN A 82PHE A 86PRO A 105GLN A 116SER A 138 | TDC A 301 ( 4.9A)TDC A 301 (-3.8A)TDC A 301 (-3.2A)TDC A 301 (-3.3A)TDC A 301 (-4.5A)TDC A 301 (-2.8A)TDC A 301 ( 3.7A) | 0.68A | 4b3aA-5mruA:24.0 | 4b3aA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B3A_A_TACA222_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 5 / 12 | LEU A 60HIS A 64SER A 67ASN A 82ILE A 137 | TDC A 301 ( 4.9A)TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)TDC A 301 ( 4.5A) | 1.33A | 4b3aA-5mruA:24.0 | 4b3aA-5mruA:47.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B3A_A_TACA222_1 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 7 / 12 | LEU A 60HIS A 64SER A 67ASN A 82PHE A 86GLN A 116SER A 138 | TDC A 301 ( 4.9A)TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)TDC A 301 (-3.3A)TDC A 301 (-2.8A)TDC A 301 ( 3.7A) | 0.73A | 4b3aA-5mruA:24.0 | 4b3aA-5mruA:47.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V2G_B_CTCB222_0 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 8 / 12 | HIS A 64ASN A 82PHE A 86HIS A 100ARG A 104PRO A 105THR A 112GLN A 116 | TDC A 301 (-3.8A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.0A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A) | 0.61A | 4v2gB-5mruA:23.2 | 4v2gB-5mruA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V2G_B_CTCB222_0 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 5 / 12 | HIS A 64SER A 67ASN A 82HIS A 100ILE A 137 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A) MG A 302 ( 3.2A)TDC A 301 ( 4.5A) | 1.43A | 4v2gB-5mruA:23.2 | 4v2gB-5mruA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V2G_B_CTCB222_0 (TETRACYCLINEREPRESSOR PROTEINCLASS D) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 9 / 12 | HIS A 64SER A 67ASN A 82PHE A 86HIS A 100PRO A 105THR A 112GLN A 116SER A 138 | TDC A 301 (-3.8A)TDC A 301 (-3.3A)TDC A 301 (-3.2A)TDC A 301 (-3.3A) MG A 302 ( 3.2A)TDC A 301 (-4.5A)NoneTDC A 301 (-2.8A)TDC A 301 ( 3.7A) | 0.75A | 4v2gB-5mruA:23.2 | 4v2gB-5mruA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MXB_A_ML1A222_1 (CLASS 10 PLANTPATHOGENESIS-RELATEDPROTEIN) |
5mru | TETRACYCLINEREPRESSOR, CLASS A (Pseudomonassp.) | 5 / 10 | THR A 136ILE A 137LEU A 191PHE A 140GLY A 197 | NoneTDC A 301 ( 4.5A)NoneNoneNone | 1.11A | 5mxbA-5mruA:undetectable | 5mxbA-5mruA:12.20 |